AEON Biopharma, Inc. — Form D/A

AEON Biopharma, Inc. of IRVINE, CA, a company, filed a Form D amendment with the SEC on 2021-05-13. The offering totals $30.0M, of which $30.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Scott AkamineExecutive OfficerNewport Beach, CA
Alex WilsonExecutive OfficerMiami, FL
Jost FischerDirectorIrvine, CA
Robert GrantDirectorSonoma, CA
Darren O'BrienDirectorIrvine, CA
Simone BlankDirectorIrvine, CA
Marc ForthExecutive OfficerIrvine, CA
Vikram MalikDirectorIrvine, CA
Richard TaketaDirectorIrvine, CA
Chris CarrExecutive OfficerIrvine, CA
Chad OhExecutive OfficerIrvine, CA
ROBERT E GRANTDirectorNEWPORT BEACH, CA
ROBERT E GRANTExecutive OfficerNEWPORT BEACH, CA
Hans S KeirsteadDirectorIrvine, CA
Juliet Tammenoms BakkerDirectorIrvine, CA
Craig Tammenoms KussmanExecutive OfficerIrvine, CA
William E LinkDirectorIrvine, CA
William E LinkExecutive OfficerIrvine, CA
Bosun Tammenoms HauDirectorIrvine, CA
Patrick S MaxwellDirectorIrvine, CA
Richard S LindstromDirectorIrvine, CA
Robert S HaymanDirectorIrvine, CA
Robert Tammenoms RhatiganExecutive OfficerIrvine, CA
Dennis Tammenoms WolfDirectorIrvine, CA
Vikram S MalikDirectorIrvine, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2022-08-11D$30.0M$30.0M
2022-08-11D$25.0M$24.5M
2020-08-31D$25.0M$25.0M
2016-08-10D$55.0M$5.5M
2015-11-20D$150.0M$80.1M
2015-01-22D$40.5M$27.0M

More